BRCA1 and ovarian cancer: It has been shown that BRCA1/2 germline mutations contribute to 10–15% of cases [4], and analysis of data from The Cancer Genome Atlas Project (TCGA [5]) has also shown that that BRCA1/2 germline mutation, somatic mutations and promoter methylation effect ovarian cancer survival [5].